口服有效的新型雄激素制剂——十一烷酸睾酮应用的初步报告
The effectiveness of testosterone undecanoate (A new orally active androgen)
-
摘要: 本文对13例男性性功能减退患者(Klinefelter综合症5例,H.H6例和垂体瘤术后2例)口服十一烷酸睾酮80mg前及之后1,2,3,4,5,6,8和10小时的血浆雄激素进行动态观察。结果发现服药后平均血睾酮(±SE)水平逐渐上升,2小时达正常男性水平;峰值(22.2±3.4nmol/l)出现在服药后4小时,但个体差异较大,范围波动在2~6小时;10小时后回到服药前水平。5例Klinefelter综合症患者增高的血LH和FSH未被抑制。4例患者连续服药(120mg/日)8周后临床上均有不同程度的雄性化表现。作者对以上现象结合文献进行了讨论,认为本药使用方便、口服有效,临床反应佳、副作用少,可作为一种雄激素替代药物,具有推广应用的价值。Abstract: Plasm testosterone(T),LH and FSH were measured in thirteen hypogonadal men before and, at hourly intervals,after the oral administration of 80 mg testosterone undecanoate(TU).The test was repeated in one man after he had taken 120 mg TU per day for eight weeks.The sexual interests and behavioural effects were studied in 4 hypogonadal male patients during eightweek administration of TU.Plasma T increased gradually,reached the xenith(22.2±3.4nmol/l)four hours after TU administration and returned to the basal level at the tenth hour.However the absorption curves showed a high interindividual variability in the time when maximum concentrations were reached,as well as in the maximum levels themselves.The increased LH and FSH in hypergonadotropics(N=5)were not suppressed.In one patient the long-term treatment made the peak occur earlier.The sexual interests and erections as well as physical activity were improved in all four patients who had taken TU for eight weeks.No side effects were complained.The convenience of oral administration,the resulting prolonged elevated plasma androgen levels and the probable lack of deleterious effects on the liver apparently render oral TU of value when androgen replacement therapy is indicated.
下载: